Mountain West AETC

University of Washington

Harborview Medical Center
Mail Stop: 359932, 325 Ninth Avenue
Seattle, WA 98104
United States

Phone
(206) 543-2704

Regional Scope

The Mountain West AETC serves Alaska, Colorado, Idaho, Montana, Oregon, North and South Dakota, Utah, Washington, and Wyoming through its central office and local partners.

Contact

For HIV training, technical assistance, and/or capacity building assistance anywhere in the Mountain West  AETC region, contact [email protected].  

Principal Investigator
Program Director
Phone: (206) 221-4943
Senior Computing Specialist
Regional Program Manager
Telehealth Manager
Phone: (206) 685-9625
Program Support Specialist
Medical Program Director
Practice Transformation Program Coordinator
Washington State Training Coordinator
Phone: (206) 543-3319
Corrections Program Director
Central and Eastern Washington Coordinator
MWAETC HIV ECHO Director/Trainer

Resources: 79

Title Sort descending Publish Date Review Date
2021 STI Treatment Guidelines Update
Addressing the Increased Risk of Lung Cancer in People with HIV
ART Update: New Guidelines & Medications
ASCVD Risk Prediction to Guide Initial Statin Therapy for People with HIV
Buprenorphine for Opioid Use Disorder
Cabotegravir plus Rilpivirine (Cabenuva): Extended Release Injectable Suspension
Cardiovascular Risks of Antiretroviral Therapy
Certification Resources for Health Care Professionals
Challenging Structural Racism in Medicine: Intro to Key Concepts of Critical Race Theory
Clinical Reference Tools for Sexually Transmitted Infections (STI) - Oregon
Clinically Relevant Drug Interactions with Direct Acting Antivirals (DAAs)
CROI Update: Prevention
Cryptococcosis in People with HIV: Updated Guidelines on Prevention & Treatment
Dapivirine Ring for HIV PrEP
Diabetes Medications for Type 2 Diabetes with Focus on HIV: Parts 1 & 2
Does this Patient Need PEP?
Expedited Partner Therapy (EPT) Fact Sheet for Providers
Expedited Partner Therapy in 2022: Updated Guidance and Practical Realities
Fall Risk Evaluation & Management
Fentanyl and Other High Potency Synthetic Opioids
Fentanyl Updates
Fentanyl: A Hidden Epidemic
Health Inequities and HIV Vulnerability
Hepatitis B Immunity in HIV: Case Vignette
Hepatitis B Prevention: New Vaccines and the Boundaries of HBV Protection
Hepatitis C Treatment Update
HIV & The Treatment of Depression
HIV and the Treatment of Depression II: Antidepressant Selection Part 1 and Part 2
HIV Drug Resistance Testing Basics
HIV Medication Chart Pad
HIV Non-Occupational Post-Exposure Prophylaxis (nPEP) and Processes of Patient Care
HIV Pre-Exposure Prophylaxis (PrEP) Expansion of Pharmacy-Delivered PrEP
HIV PrEP: Future of PrEP
Immune Reconstitution Syndrome, 2023-Part 2
Implementing Substance Use Disorder (SUD) Services in HIV Care Settings Toolkit
Implementing Telemedicine Webinar Series
Integrating Behavioral Health into Primary HIV Care — Covering the Bases
Introducing NASTAD's Updated PrEP, PEP, and other HIV Prevention Strategies: Billing and Coding Guide
Isolated Hepatitis B Core Antibody in People with HIV Infection
Management of HCV and HIV Coinfection
Medications for Methamphetamine Use Disorder
Microaggressions in Healthcare: How to Respond
Microaggressions in Healthcare: Patient Experiences
Operationalizing Use of Long-Acting Injectable ART
Pain Management in Individuals with Substance Use Disorders
Pneumocystis Pneumonia: Part 1
Pneumocystis Pneumonia: Prevention & Treatment
Practical Approaches to Polypharmacy
PrEP for HIV Prevention: The 4-1-1 on 2-1-1
PrEP for Prevention of HIV in the U.S., 2021 Update
PrEP for PWID: Challenges and Opportunities
PrEP for Transgender Patients Update
Prevention and Treatment of Hepatitis C Infection among People who Use Drugs
Primary Care Considerations for Patients Using Methamphetamines
Recent Trials of Second-Line ART: Lessons Learned & Applications to Clinical Practice
Results and Response to a 10-State COVID-19 Practice Impact Survey in the Mountain West Region
Revisiting the Invisible Latino HIV Crisis: Examining Progress and Identifying Remaining Gaps in the National Response
Risk of HIV Transmission with Low Levels of Viremia
Risk, Presentation, Treatment, and Outcomes of COVID-19 in People with HIV
Screening and Treatment of HPV Lesions to Reduce Anal Cancer: ANCHOR Results and Implications
Sexual History Taking
Stigma and Addiction Training Slides
STIs and PrEP for People Who Inject Drugs
Suicide and Overdose among People with HIV during the COVID-19 Pandemic: Updates and Opportunities for Mitigation
Telemedicine and Opioid Use Disorder (OUD) Part 2: Clinical Tips
Telemedicine and Opioid Use Disorder: Regulatory Changes and Evidence
Telemedicine for People with HIV
Treating Hepatitis C Among People who Use Drugs
Treatment for STIs: A Guide for Medical Providers
Understanding Frailty
Unhealthy Alcohol Use Among Persons with HIV: A Modifiable Barrier to Optimal Management of HIV and its Comorbidities
Updates in TB Preventive Therapy Guidelines
Updates to Testing and Prophylaxis for Infants with HIV Exposure
Updates to the HHS Adult and Adolescent HIV Treatment Guidelines
Using HIV-ASSIST to Guide ART Decision-Making
Vaccine Update: COVID-19 and RSV
What will PrEP Implementation Look Like Post-COVID?
“IM” Thinking About Using Long Acting Injectables
“Microdosing” Buprenorphine Inductions
Day Title
06/06 to 06/07 2024 Mountain West AETC HIV Clinical Update for Nurses Conference (Washington)
Thursday, June 6, 2024 - 8:00am EDT to Friday, June 7, 2024 - 4:30pm EDT
Event type: Conferences & Events
05/06 to 05/07 Addressing the Challenges of Rural HIV Case Management (Wyoming)
Monday, May 6, 2024 - 8:00am EDT to Tuesday, May 7, 2024 - 1:30pm EDT
Event type: Conferences & Events